IDIrma W. E. M. van Dijk

Irma W. E. M. van Dijk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Irma W. E. M. van Dijk has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Huib N. Caron

    Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands

    4 shared publications
  • Caro C.E. Koning

    Department of Radiation Oncology, Academic Medical Center, Amsterdam, The Netherlands

    3 shared publications
  • Cecile M. Ronckers

    German Childhood Cancer Registry/Division of Childhood Cancer Epidemiology, IMBEI University Medicine at the Johannes Gutenberg University Mainz, Mainz, Germany

    3 shared publications
  • Flora E. van Leeuwen

    Department of Epidemiology, Netherlands Cancer Institute, Academic Medical Center, Amsterdam, The Netherlands

    3 shared publications
  • Foppe Oldenburger

    Department of Radiation Oncology, Academic Medical Center, Amsterdam, The Netherlands

    3 shared publications
  • Helena J.H. van der Pal

    Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, The Netherlands

    3 shared publications

Latest Publications

  • Open Access

    Predictive value of pediatric respiratory-induced diaphragm motion quantified using pre-treatment 4DCT and CBCTs

    by Sophie C. Huijskens, Irma W. E. M. van Dijk, Jorrit Visser, Brian V. Balgobind, Coen R. N. Rasch, Tanja Alderliesten, Arjan Bel

    In adults, a single pre-treatment four-dimensional CT (4D-CT) acquisition is often used to account for respiratory-induced target motion during radiotherapy. However, studies have indicated that a 4D-CT is not always representative for respiratory motion. Our aim was to investigate whether respiratory-induced diaphragm motion in children on a single pre-treatment 4DCT can accurately predict respiratory-induced diaphragm motion as observed on cone beam CTs (CBCTs). Twelve patients (mean age 14.5 yrs.; range 8.6–17.9 yrs) were retrospectively included based on visibility of the diaphragm on abdominal or thoracic imaging data acquired during free breathing. A 4DCT for planning purposes and daily/weekly CBCTs (total 125; range 4–29 per patient) acquired prior to dose delivery were available. The amplitude, corresponding to the difference in position of the diaphragm in cranial-caudal direction in end-inspiration and end-expiration phases, was extracted from the 4DCT (A4DCT). The amplitude in CBCTs (ACBCT) was defined as displacement between averaged in- and expiration diaphragm positions on corresponding projection images, and the distribution of ACBCT was compared to A4DCT (one-sample t-test, significance level p < 0.05). Over all patients, the mean A4DCT was 10.4 mm and the mean ACBCT 11.6 mm. For 9/12 patients, A4DCT differed significantly (p < 0.05) from ACBCT. Differences > 3 mm were found in 69/125 CBCTs (55%), with A4DCT mostly underestimating ACBCT. For 7/12 patients, diaphragm positions differed significantly from the baseline position. Respiratory-induced diaphragm motion determined on 4DCT does not accurately predict the daily respiratory-induced diaphragm motion observed on CBCTs, as the amplitude and baseline position differed statistically significantly in the majority of patients. Regular monitoring of respiratory motion during the treatment course using CBCTs could yield a higher accuracy when a daily adaptation to the actual breathing amplitude takes place.


  • Heart volume reduction during radiotherapy involving the thoracic region in children: An unexplained phenomenon

    by Irma W.E.M. van Dijk, Jorrit Visser, Jan Wiersma, Jessica R. van Boggelen, Brian V. Balgobind, Elizabeth A.M. (Lieke) Feijen, Sophie C. Huijskens, Wouter E.M. Kok, Leontien C.M. Kremer, Coen R.N. Rasch, et al.


  • Open Access

    Interfractional renal and diaphragmatic position variation during radiotherapy in children and adults: is there a difference?

    by Irma W. E. M. van Dijk, Sophie C. Huijskens, Rianne de Jong, Jorrit Visser, Raquel Dávila Fajardo, Coen R. N. Rasch, Tanja Alderliesten, Arjan Bel

    Background: Pediatric safety margins are generally based on data from adult studies; however, adult-based margins might be too large for children. The aim of this study was to quantify and compare interfractional organ position variation in children and adults. Material and methods: For 35 children and 35 adults treated with thoracic/abdominal irradiation, 850 (range 5–30 per patient) retrospectively collected cone beam CT images were registered to the reference CT that was used for radiation treatment planning purposes. Renal position variation was assessed in three orthogonal directions and summarized as 3D vector lengths. Diaphragmatic position variation was assessed in the cranio-caudal (CC) direction only. We calculated means and SDs to estimate group systematic (Σ) and random errors (σ) of organ position variation. Finally, we investigated possible correlations between organ position variation and patients’ height. Results: Interfractional organ position variation was different in children and adults. Median 3D right and left kidney vector lengths were significantly smaller in children than in adults (2.8, 2.9 mm vs. 5.6, 5.2 mm, respectively; p < .05). Generally, the pediatric Σ and σ were significantly smaller than in adults (p < .007). Overall and within both subgroups, organ position variation and patients’ height were only negligibly correlated. Conclusions: Interfractional renal and diaphragmatic position variation in children is smaller than in adults indicating that pediatric margins should be defined differently from adult margins. Underlying mechanisms and other components of geometrical uncertainties need further investigation to explain differences and to appropriately define pediatric safety margins.


  • Risk of Symptomatic Stroke After Radiation Therapy for Childhood Cancer: A Long-Term Follow-Up Cohort Analysis

    by Irma W.E.M. van Dijk, Helena J.H. van der Pal, Rob M. van Os, Yvo B.W.E.M. Roos, Elske Sieswerda, Elvira C. van Dalen, Cécile M. Ronckers, Foppe Oldenburger, Flora E. van Leeuwen, Huib N. Caron, et al.


  • The use of equivalent radiation dose in the evaluation of late effects after childhood cancer treatment

    by Irma W. E. M. van Dijk, Rob M. van Os, Jeroen B. van de Kamer, Nicolaas A. P. Franken, Helena J. H. van der Pal, Caro C. E. Koning, Huib N. Caron, Cécile M. Ronckers, Leontien C. M. Kremer

    In epidemiologic research radiation-associated late effects after childhood cancer are usually analyzed without considering fraction dose. According to radiobiological principles, fraction dose is an important determinant of late effects. We aim to provide the rationale for using equivalent dose in 2-Gy fractions (EQD2 α/β ) as the measure of choice rather than total physical dose as prescribed according to the clinical protocol. Between 1966 and 1996, 597 (43.8 %) children in our cohort of 1,362 5-year childhood cancer survivors (CCS) received radiotherapy before the age of 18 years as part of their primary cancer treatment. Detailed information from individual patients’ charts was collected and physical doses were converted into the EQD2 α/β , which includes total dose, fraction dose, and the tissue-specific α/β ratio. The use of EQD2 α/β is illustrated in examples studies describing different analyses using EQD2 α/β and physical dose. Radiotherapy information was obtained for 510 (85.4 %) CCS. Multivariable analyses rendered different risk estimates for total body irradiation in EQD2 α/β -based vs. physical-dose-based models. For other radiotherapy regimens, risk estimates were similar. Using the total physical dose is not adequate for advanced analyses of radiation-associated late effects in CCS. Therefore, it is advised that for future studies the EQD2 α/β is used, because the EQD2 α/β incorporates the fraction dose, and the tissue-specific α/β ratio. Furthermore, it enables comparisons across fractionation regimens and allows for summing doses delivered by various contemporary and future radiation modalities. Risk estimates of radiation-associated side effects expressed in EQD2 α/β provide more precise, clinically relevant information for cancer survivor screening guidelines.


  • Dose-Effect Relationships for Adverse Events After Cranial Radiation Therapy in Long-term Childhood Cancer Survivors

    by Irma W.E.M. van Dijk, Mathilde C. Cardous-Ubbink, Helena J.H. van der Pal, Richard C. Heinen, Flora E. van Leeuwen, Foppe Oldenburger, Rob M. van Os, Cécile M. Ronckers, Antoinette Y.N. Schouten–Van Meeteren, Huib N. Caron, et al.


  • Evaluation of Late Adverse Events in Long-Term Wilms' Tumor Survivors

    by Irma W.E.M. van Dijk, Foppe Oldenburger, Mathilde C. Cardous-Ubbink, Maud M. Geenen, Richard C. Heinen, Jan de Kraker, Flora E. van Leeuwen, Helena J.H. van der Pal, Huib N. Caron, Caro C.E. Koning, et al.